Is that why Caladrius Biosciences, (CLBS) share price dropped in the post-market session

Caladrius Biosciences, (CLBS). Shares dropped -7.59% to $1.34 in the after-market session after it was reported that the agenda for the quarterly Life Sciences Investor Forum is available for public and private companies across the world, as well as investors and industry professionals. Throughout the day, a live company presentation and interactive discussion will be held regarding the life sciences industry.

Investors, advisors and analysts are encouraged to attend. The event begins at 9:30 AM ET Thursday, December 17th.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Most Popular

Related posts